Bitcoin, ETH, XRP Rally Over 2% as Funding Rates Triple: What's Going On?
Bitcoin, Ethereum and XRP rise as bullish derivatives bets build and Fed rate-hike odds fall before the US jobs report.
Crypto · News reference
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)
U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's lower close.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bitcoin Holds a 'Unique' Place in the Conversation as Treasury Yields Hit 24-Year Highs: Will Fed Choose Inflation or Bond Market Stability?
Stephen Coltman, Head of Macro at 21Shares, said the Federal Reserve may tolerate elevated inflation over the long run to maintain stability of government bond markets, putting currency debasement and Bitcoin back in the spotlight.
Stock Market Today: S&P 500, Dow Jones Futures Gain as Investors Await September's Jobs Report Data — NKE, SYNA, CTVA in Focus
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
Paul Atkins Says SEC Will End ‘Grey of Uncertainty’ Around Crypto — New Proposal Puts Custody in Spotlight
SEC Chair Paul Atkins spotlighted on Thursday, October 1, the SEC's new proposal to create a regulatory framework for the custody of cryptocurrencies
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pact; Mangoceuticals drops.
Edwards Lifesciences Says FDA Approves AUTUS Size-Adjustable Valve, Surgical Pulmonary Valve Designed For Pediatric Patients With Congenital Heart Disease
Edwards Lifesciences (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with